Veru Inc. announced the appointment of Jason Davies as Executive Vice President General Manager of Europe, the Middle East and Africa (EMEA), Latin America (LATAM), and Asia Pacific (APAC) for Verus Infectious Disease Franchise for Veru International. Most recently Mr. Davies had been the EMEA Head of Launch Excellence Pharmaceutical Portfolio at Janssen (Johnson &Johnson) where he was responsible for creating and leading a new organization to enhance launch strategy and execution across all of Janssens EMEA pharmaceutical portfolio. Prior to this role, Mr. Davies had spent approximately 20 years in a number of commercial positions of increasing responsibility spread across Janssens business units, including pharmaceutical business unit P&L responsibility, sales, marketing, market access, integration and strategy, with a focus on pharmaceuticals for virology/infectious disease and many other therapeutic areas.

Jason is an accomplished experienced commercial leader with extensive knowledge in viral infectious disease product commercialization and ex-U.S. product launches, said Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru Inc.